biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦11:51 Putting force on old mice's leg bones helped them live about 9% longer✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦11:54 Cold helps worms live longer via a chemical their muscles send out✦06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦11:51 Putting force on old mice's leg bones helped them live about 9% longer✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦11:54 Cold helps worms live longer via a chemical their muscles send out
← People to follow
BA
PERSON TO FOLLOW

Brian Armstrong

Co-founder and CEO of Coinbase; co-founder of NewLimit

Built Coinbase into the largest crypto exchange in the United States and co-founded the longevity company NewLimit in 2021. He has called reversing cellular aging the most important problem he could work on after crypto.

epigenetic reprogramminglongevity fundingcellular aging

WHAT TO WATCHHis public statements as NewLimit moves its first drug toward human testing.

ON THE WIRE

Every story about Brian’s work.

Profile sources

  1. 1
    Longevity Science Attracts Mainstream Tech Founders TradeFlock
  2. 2
    NewLimit — $3.1B · CEO Jacob Kimmel Silicon Valley Investclub
  3. 3
    NewLimit: Using Epigenetic Reprogramming to Reverse Cellular Excedr